PI3Kdelta-IN-25 is an orally active selective PI3Kdelta inhibitor (IC50 = 2.1 nM). PI3Kdelta-IN-25 has IC50s of 272, 285, and 1171 nM for PI3Kalpha, PI3Kgamma, and PI3Kbeta, respectively. PI3Kdelta-IN-25 inhibits AKT Ser473 phosphorylation, suppresses Treg cell proliferation, and downregulates PD-L1 expression in B16F10 cells. PI3Kdelta-IN-25 exhibits anticancer effects in B16F10 melanoma and Lewis lung cancer mouse models by reducing tumor-infiltrating Treg cells and enhancing immune responses. PI3Kdelta-IN-25 is potentially useful in the study of melanoma, lung cancer, and other cancers[1].
Molekulargewicht:
552.67
Formel:
C26H28N6O4S2
Target-Kategorie:
Akt,CD3,Interleukin Related,PD-1/PD-L1,PI3K
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
